Literature DB >> 28695911

Haematological cancer: Low-dose CAR T cells are safe and effective.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28695911     DOI： 10.1038/nrclinonc.2017.107

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients.

Authors:  J Pan; J F Yang; B P Deng; X J Zhao; X Zhang; Y H Lin; Y N Wu; Z L Deng; Y L Zhang; S H Liu; T Wu; P H Lu; D P Lu; A H Chang; C R Tong
Journal:  Leukemia       Date:  2017-05-15       Impact factor: 11.528
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.